首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Measuring polio immunity to plan immunization activities
【2h】

Measuring polio immunity to plan immunization activities

机译:测量脊髓灰质炎免疫力以计划免疫活动

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Global Polio Eradication Initiative is closer than ever to achieving a polio-free world. Immunization activities must still be carried out in non-endemic countries to maintain population immunity at levels which will stop poliovirus from spreading if it is re-introduced from still-infected areas. In areas where there is no active transmission of poliovirus, programs must rely on surrogate indicators of population immunity to determine the appropriate immunization activities, typically caregiver-reported vaccination history obtained from non-polio acute flaccid paralysis patients identified through polio surveillance. We used regression models to examine the relationship between polio vaccination campaigns and caregiver-reported polio vaccination history. We find that in many countries, vaccination campaigns have a surprisingly weak impact on these commonly used indicators. We conclude that alternative criteria and data, such as routine immunization indicators from vaccination records or household surveys, should be considered for planning polio vaccination campaigns, and that validation of such surrogate indicators is necessary if they are to be used as the basis for program planning and risk assessment. We recommend that the GPEI and similar organizations consider or continue devoting additional resources to rigorously study population immunity and campaign effectiveness in at-risk countries.
机译:全球根除脊髓灰质炎行动比以往任何时候都更接近实现无脊髓灰质炎的世界。在非流行国家中,仍必须进行免疫活动,以保持人群的免疫水平,如果从仍然受感染​​的地区再次引入脊髓灰质炎病毒,则将阻止脊髓灰质炎病毒的传播。在没有主动传播脊髓灰质炎病毒的地区,计划必须依靠人群免疫力的替代指标来确定适当的免疫活动,通常是从由脊髓灰质炎监测确定的非策略性急性弛缓性瘫痪患者获得的护理人员报告的疫苗接种史。我们使用回归模型检查了小儿麻痹症疫苗接种活动与护理人员报告的小儿麻痹症疫苗接种历史之间的关系。我们发现,在许多国家,疫苗接种运动对这些常用指标的影响令人惊讶地微弱。我们得出结论,在规划脊髓灰质炎疫苗接种运动时,应考虑替代标准和数据,例如来自疫苗接种记录或家庭调查的常规免疫指标,并且如果要使用这些替代指标作为计划制定的基础,则必须对其进行验证和风险评估。我们建议GPEI和类似组织考虑或继续投入更多资源,以严格研究高风险国家的人口免疫力和运动效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号